A "vaccine" which harnesses the body's own immune system to fight prostate cancer has been approved for use by US drug regulators. Provenge - which is designed to be used in men with advanced disease - is the first of its kind to be accepted by the Food and Drug Administration.
FDAが「PROVENGE」を前立腺癌患者の治療に用いることを承認したと発表した。
This latest therapy is made by collecting special blood cells from each patient that help the immune system recognise cancer as a threat. It is an expensive treatment at $93,000 per patient.
Provengeは患者自身の白血球細胞から作られる前立腺がんワクチンである。
Provenge治療は高額ではあるけど副作用が少なく臨床データも良好。
最近は自分でレッスンのトピックを選べるようになった。
でも偏らないようにしないと・・
